Etienna Bio Secures Exclusive Global License From UMass Chan for Adipose-Derived Cell and Matrix Platform

Etienna Bio, Inc., a biotechnology company focused on next-generation autologous and cell-enabled biomaterials for regenerative and aesthetic application...

January 12, 2026 | Monday | News
Aragen Launches CHOMax™ Platform to Accelerate Monoclonal Antibody Development from DNA to IND

Accelerated pathway: Integrated cell line development, process development, analytics, GMP drug substance, plus drug product support through quali...

January 12, 2026 | Monday | News
Nucleome Therapeutics Nominates First-in-Class Monoclonal Antibody Programme Targeting Inflammation Resolution

First-in-class monoclonal antibody agonist programme for inflammation resolution with broad applicability across major chronic inflammatory diseases...

January 08, 2026 | Thursday | News
Kelun-Biotech’s TROP2 ADC sac-TMT Combo with Keytruda Granted Breakthrough Therapy Designation in China for First-Line NSCLC

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK)  announced that its TROP2-directed antibody-drug ...

January 06, 2026 | Tuesday | News
Ironwood CEO Tom McCourt Outlines Strong 2026 Outlook, Forecasting Up to $1.175B in LINZESS U.S. Net Sales and Adjusted EBITDA Above $300M

- Expects full-year 2026 LINZESS® U.S. net sales of $1.125 to $1.175 billion; total revenues of $450 to $475 million and adjusted EBITDA of greater...

January 05, 2026 | Monday | Company results
Zenas BioPharma Shares Slide On Phase 3 Data Focus

    Market participants appear to be adopting a wait and watch stance, with sentiment shaped less by near term fundamentals and more by expecta...

January 05, 2026 | Monday | News
Zevra Therapeutics Signs Exclusive Expanded Access Distribution Deal With Uniphar for MIPLYFFA

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare ...

December 31, 2025 | Wednesday | News
Viva Biotech Showcases Integrated PK/PD Platform Across Small Molecules, Peptides, PROTACs, and Antibodies

Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and m...

December 30, 2025 | Tuesday | News
ABL Bio Secures $55M from Eli Lilly to Accelerate Grabody Platform Expansion

- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D o...

December 29, 2025 | Monday | News
SN Bioscience’s SNB-101 Secures FDA Orphan Drug Designation for Gastric Cancer

SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (including gast...

December 25, 2025 | Thursday | News
Mondego Bio Selects Lead PTPN2 Inhibitor ZE00-0388, Enters Clinical Stage

Mondego Bio, a clinical-stage biotechnology company developing next-generation small-molecule immuno-oncology therapies, announced the formal selection o...

December 23, 2025 | Tuesday | News
Allink Biotherapeutics Secures $47M to Accelerate Next-Generation ADC and Multispecific Antibody Pipeline

The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with stron...

December 17, 2025 | Wednesday | News
Neupulse Launches Drug-Free Wearable Offering New Hope for People Living With Tourette Syndrome

Neurotechnology company Neupulse has announced a first-of-its-kind wearable device proven to dramatically reduce the frequency and urge of tics in people l...

December 17, 2025 | Wednesday | News
Thermo Fisher Launches Next-Gen Chemically Defined Media to Accelerate Scalable Plasmid DNA Production

  New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence Thermo Fisher Scien...

December 16, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close